Losartan HCTZ 50/12.5 mg, 90 count bottle Original NDC# 33342-0050-10 Repackaged NDC# 70518-3231-00
Published June 1, 2022 · Recall initiated: May 4, 2022
Summary
FDA records drug Class II recall D-0885-2022, published June 1, 2022 and initiated May 4, 2022. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 22 bottles/90 count each; Lot: Lot # B1377711-100521, exp. date 10/31/2022 B1412137-102621, exp. date 10/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- RemedyRepack Inc.
- Distributor
- Recalled product was distributed to Florida.
- Lot
- Lot # B1377711-100521, exp. date 10/31/2022 B1412137-102621, exp. date 10/31/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc.,April 30, 2025
- FDACarvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark,February 12, 2025
- FDADuloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottlesJanuary 1, 2025
- FDAPotassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG:July 24, 2024
- FDALosartan HCTZ 100/25 mg, 90 count bottles NDC# 70518-2578-00 Repackaged NDC Original NDC # 68180-0217-09June 1, 2022
- FDACAIRE FreeStyle Comfort Portable Oxygen Concentrator with autoSAT, UltraSense and autoDOSE, model #AS200-3May 25, 2022
Questions about this recall
Was Losartan HCTZ 50/12.5 mg, 90 count bottle Original NDC# 33342-0050-10 Repackaged NDC# 70518-3231-00 recalled?
Yes. FDA published recall D-0885-2022 on June 1, 2022. Reported hazard: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
What should I do if I have this product?
Voluntary: Firm initiated · Letter